Becker's Healthcare January 30, 2023
Pharmaceutical giant Pfizer invested $25 million Ribon Therapeutics, a biotech company working to develop therapeutics targeting stress support pathways in cancer and inflammatory diseases.
Ribon plans to use the investment to support the clinical development of its oral small molecule programs in oncology and immunology. Additionally, the company has partnered with Pfizer to support the advancement of its drug pipeline by leveraging...
Today's Sponsors
Today's Sponsor